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Brugada syndrome is an inherited disease that causes sudden death because of ventricular ﬁbrillation.
Its prevalence is approximately 0.15% in adults and 0.005% in children in Asia, and less than 0.02% in the
West. The reason for the higher prevalence in Asia is likely ethnic-speciﬁc polymorphisms modulating
the activity of the primary disease-causing mutation. In Japan, the incidence of Brugada-pattern
electrocardiogram (ECG) is 14.2 per 100,000 person-years. Data from multicenter registries indicate
that its frequency in men with Brugada syndrome is higher in Japanese patients (94–96%) than in
Caucasian patients (72–80%). Healthy individuals with Brugada-type ECG have a favorable prognosis
with an annual death rate of less than 0.5%.
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Brugada syndrome (BS) is a clinical entity that causes sudden
death because of ventricular ﬁbrillation (VF) in patients with
apparently structurally normal hearts, and it is characterized by
coved ST-segment elevation in the right precordial leads (V1–V3)
[1,2]. A similar clinical condition, which brings sudden death mainly
at night in young and middle-aged men, has been known in Asian
countries by different names such as ‘‘pokkuri’’ in Japan, ‘‘lai-tai’’ in
Thailand, and ‘‘bangungut’’ in the Philippines. Several cases of
pokkuri or idiopathic VF that showed coved ST elevation just after
resuscitation were reported in Japan [3,4] in 1990 (Fig. 1) before
Brugada et al. ﬁrst described this condition in 1992. In 1990, we also
reported that some patients demonstrate a peculiar ST elevation in
the leads V1–V3 and develop a syncopal attack at midnight or early
morning in a series of four cases with idiopathic VF [4].rt Rhythm Society. Published by EWith respect to the ST elevation in the precordial lead,
Antzelevitch et al. demonstrated that this can be an expression of
early repolarization or J-wave caused by transient outward current
(Ito)-mediated transmural differences in the early phases of the
action potential. BS is an inherited disease with a heterogeneous
genetic basis [5]. More than 11 genes have been linked to this
disease in the last 15 years, although mutations in SCN5A are the
most commonly found mutations in 15–30% of Brugada patients.2. Prevalence of Brugada syndrome in Japan
BS is responsible for 4% of all sudden deaths and for up to 20%
of sudden deaths in patients without structural heart disease [2,6].
The estimated prevalence of BS ranges from 4 to 122 per 10,000
inhabitants in Japan. However, many of these reports were pub-
lished before 2002 when the consensus report for BS was proposed
[7]; thus, the 12-lead electrocardiogram (ECG) deﬁnition in many
reports included not only the coved ST elevation but also the
saddleback ST elevation with a J-wave of amplitude Z1 mmlsevier B.V. All rights reserved.
Fig. 1. 12-Lead ECGs of a case who recovered from ‘‘pokkuri’’. A 41-year-old man was admitted to the local hospital for syncope accompanied by agonizing respiration at
night. A 12-lead ECG on admission at 4:00 AM on 6 August 1988 showed a prominent coved ST elevation in leads V1 and V2 without T-wave inversion (Fig. 1A). These
T-waves became inverted 7 months after admission (25 March 1989), although the coved ST elevation in leads V1 and V2 continued to be observed (Fig. 1B). Modiﬁed, with
permission, from Motoki and Tsujimura [3].
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considered to be an essential ECG feature for BS at that time.
Miyasaka et al. reported that the coved ST elevation Z1 mm with
RBBB was found in 0.12% of 13,929 subjects, with a prevalence of
0.38% in men and 0.03% in women, who were screened during
annual health examinations in Moriguchi-city, Osaka [8]. They also
indicated that Brugada-pattern ECG was recognized in 0.7% of all
subjects but was higher in men (2.14%) when saddleback ST
elevation Z1 mm was also included in the Brugada-pattern. In
the same study cohort in Moriguchi, Tsuji et al. later reported that
0.26% of subjects demonstrated type 1 Brugada-pattern ECG with or
without RBBB [9]. Atarashi et al. evaluated 10,000 ECGs obtained
during annual check-ups of working adults in the Tokyo area and
found that 16 men (0.16%) showed coved-type ST elevation Z1 mm
with RBBB in the right precordial leads [10]. In addition, Matsuo
et al. reported that the prevalence of Brugada-pattern ECG with
coved or saddleback ST elevation Z1 mmwas 0.146% in a survey of
ECG records of 4788 atomic-bomb survivors who underwent
biennial health examination for 40 years in Nagasaki [11]. Furuhashi
et al. also reported that the prevalence of Brugada-pattern ECG was
0.14% in 8612 healthy subjects [12]. A report with an inclusion
criterion for Brugada-type ECG of ST elevation 42 mm with or
without RBBB was published by Sakabe et al. [13]. They evaluated
ECGs of 3339 healthy adult subjects who underwent medical
examinations annually from 1992 to 2001 and reported that an
average 0.28% of subjects showed coved-type ST elevation in the
right precordial lead. They also indicated that the majority (97%) of
subjects who showed coved-type or saddleback-type ST elevation
(1.22%) were men.
Oe et al. studied the prevalence of BS in juveniles [14]. They
reported that only one (0.005%) of 21,944 ﬁrst-year elementary
school children (6–7 years old) showed a type 1 ECG, and three
showed type 2 or type 3 ECGs. Yamakawa et al. investigated the
prevalence of Brugada-type ECG (types 1–3) in 20,387 school
children between the ﬁrst grade and tenth grade (from primary
school to high school) [15]. They found that only one (0.07%) malestudent (15 years old) showed a type 1 ECG and one female
student (15 years old) showed a type 2 ECG among 1328 high
school students. In addition, none of the younger children showed
type 1 ECGs, and nine school children had coved or saddleback ST
elevation with J-wave amplitude between 1 mm and 2 mm. They
also demonstrated that the prevalence of the Brugada-pattern
ECG increased with age (ﬁrst graders, 0.01%; fourth graders,
0.05%; seventh graders, 0.08%; and tenth graders, 0.23%).
Although typical Brugada-type ECG does not always appear and
the ECG changes can ﬂuctuate over time, these results indicate that
the Japanese prevalence of BS or type 1 ECG, which is recorded on
the standard 12-lead ECG without any provocation methods, can be
estimated to be less than 0.005% in children and between 0.12% and
0.28% in adults.3. Prevalence of Brugada syndrome in the rest of the world
The prevalence of BS is lower in Western countries than in
Japan, even when the classiﬁcation of Brugada-type ECG is
required to have a J-wave amplitude Z2 mm and type 1 ECG is
required to have an inverted T-wave, because most studies have
been conducted after 2002 when the consensus report was
published. Data from the Copenhagen City Heart Study, Denmark,
in which a total of 42,560 ECGs were registered from 18,974
participants, showed no type 1 Brugada-pattern and 14 type 2 or
3 patterns [16]. In that study, Pecini et al. reported that the
prevalence of BS was 0% and that of Brugada-type ECG was 0.07%,
although the representative ECG of the type 2 Brugada-pattern
clearly showed coved ST elevation with T-wave inversion in lead
V2 [16]. Junttila et al. investigated the prevalence of BS in 2479
young subjects and 542 middle-aged subjects in the Finnish
population and found no type 1 ECG and 15 (0.61%) type 2 or
3 ECGs [17]. Sinner et al. reported that not a single individual
showed a Brugada-type ECG in the investigation of 12-lead
resting ECGs of 4149 German subjects [18]. Letsas et al. reported
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in a Greek tertiary hospital; 0.02% of subjects demonstrated type
1 ECGs and 0.2% demonstrated type 2 or 3 ECGs [19]. In a report
from Italy and the United Kingdom, 0.016% of 12,012 healthy
subjects showed type 1 ECGs and 0.26% showed Brugada-type
ECGs [20]. Likewise, Brugada-type ECG has infrequently been
identiﬁed in the United States (0.012%) [21] and in Canada (0.07%)
[22]. The prevalence of Brugada-pattern ECG with J-wave ampli-
tude Z1 mm was reported by Hermida et al. from France [23].
They reported that the typical coved pattern was identiﬁed in
0.1% and the saddleback pattern was observed in 6% of 1000
subjects.
In contrast, the prevalence of BS or Brugada-type ECG in Asian
countries is relatively high. Type 1 ECG has been identiﬁed in 0.17%
of 3907 asymptomatic Filipinos [24] and in 0.13% of 20,652
Taiwanese patients who visited the hospital for non-cardiovascular
reasons [25]. Brugada-type ECG has been observed in 0.9% of 10,867
young, healthy Korean men [26]. At a heart rhythm clinic in
Singapore, 12 of 392 male patients (3.1%) showed type 1 ECGs and
28 (7.1%) showed Brugada-type ECGs [27]. In Pakistan, the Brugada-
type ECG pattern frequency was reported to be 0.8% [28]. The
prevalence of BS in the southern Turkish population seems to show
an intermediate value compared to that in Asian and Western
countries. Bozkurt et al. reported that one of 1238 subjects (0.08%)
demonstrated a type 1 ECG and ﬁve (0.74%) showed type 2 or
3 ECGs [29]. Overall, the prevalence of BS in adults is estimated to be
around 0.15% in Asian countries, including Japan, between 0.1% and
0.02% in Middle Eastern countries, and less than 0.02% in Western
countries.
As for the reason why the prevalence is high in Asian people, it
has been reported that common ethnic-related genetic poly-
morphisms might modulate the activity of the primary disease-
causing mutation or inﬂuence susceptibility to arrhythmia.
Bezzina et al. identiﬁed a haplotype variant consisting of six
individual DNA polymorphisms, designated haplotype B, in near-
complete linkage disequilibrium within the proximal promoter
region of the SCN5A gene in Asians only and not in Caucasians or
African-Americans [30]. They concluded that haplotype B does
not give rise to BS, but it likely contributes to a higher incidence of
BS in the Asian population.4. Incidence of Brugada syndrome in Japan
Matsuo et al. reported that the incidence of Brugada-pattern
ECG, including coved and saddleback ST elevation Z1 mm was
14.2 persons per 100,000 person-years in a 40-year survey of
4788 atomic bomb survivors o50 years of age in Nagasaki [11].
This rate was nine times higher among men than women (31.4 vs.
3.5 persons, respectively, per 100,000 person-years), and the
average age at presentation was 45710 years, although the peak
incidence was observed in patients in their thirties.5. Gender difference in Brugada syndrome
Despite the equal genetic transmission of the mutation
between the sexes, the clinical phenotype is much more prevalent
in men than in women. In Japan, community-based population
studies have revealed that Brugada-pattern ECGs (coved or
saddleback ST elevation Z1 mm) predominate in men (490%).
Miyasaka et al. reported that the prevalence in men was 0.38% in
contrast to 0.03% in women [8]. In another cohort study in which
41% of the subjects were men, the percentage of men with
Brugada-pattern ECG was 84% [11]. On the other hand, men with
Brugada-pattern ECG comprised 97% of all Brugada subjects in acohort study that included 79% men [13] and 100% in a study that
included 89% men [10]. Tsuji et al. reported that the frequency of
men with type 1 ECG was 84% in a survey in which 26% of all ECGs
were obtained from men [9]. The data from multicenter BS
registries indicate that the frequency of men with type 1 ECG
was 94–96% [31,32]. Therefore, the sex-adjusted rate of type
1 ECG in adult men probably reaches 90–96% in Japan. The
frequency of boys in the ﬁrst grade with Brugada-pattern ECG
was reported to be 50% [14] (two in 11,282 boys vs. two in 10,662
girls), but it became 90% after the fourth grade [15].
Regarding this gender difference in BS, Di Diego et al. sug-
gested a cellular basis for the male predominance in BS using
arterially perfused canine right ventricular (RV) wedge prepara-
tion [33]. They reported that the Ito-mediated phase 1 action
potential notch in the RV epicardium, which was larger in male
dogs than in female dogs, was responsible for the male predomi-
nance of the Brugada phenotype. Shimizu et al. suggested that the
level of the male hormone, testosterone, which is reported to
increase the outward potassium currents, was signiﬁcantly higher
and body mass index (BMI) was signiﬁcantly lower in men with
Brugada than in the controls [34]. In addition, Tsuji et al. reported
that the BMI of subjects with the Brugada-pattern ECG was
signiﬁcantly lower than that of subjects without BS in a study
with a large number of subjects [9]. The fact that the testosterone
levels in males peak during the teen and early adult years and the
incidence of Brugada-pattern ECG peaks in the thirties [11], even
though the genders show a similar prevalence in childhood [14],
may suggest that gender differences are linked to the testosterone
level depending on age.
Letsas et al. reported that the prevalence of Brugada-type ECG
was 0.34% in men and 0.04% in women in the Greek population
[19]. Despite the similar BS gender differences between the
Greeks and the Japanese, many multicenter studies performed
in Western countries indicated that the frequency of men with BS
(72–80%) [35–39] was much lower than that of the Japanese
population (94–96%) [31,32]. The reason for this national differ-
ence in gender-related frequency in BS is not completely under-
stood. Racial difference or higher BMI in Caucasian men might
have an inﬂuence on the severity of Brugada phenotype manifes-
tation. Another reason may be the difference of BS cohorts
between Western multicenter studies and Japanese BS registries.
The former included a signiﬁcant number of family members in
whom type 1 ECG was induced by drug provocation tests, while
the latter mainly consisted of probands who had spontaneous
type 1 ECG. The fact that patients with a milder phenotypic
expression of BS make up a considerable proportion of subjects in
studies from Western countries, may result in the higher rate of
inclusion of women in Western registries.6. Prognosis of healthy individuals showing Brugada-pattern
ECG
The prognosis of healthy subjects with Brugada-pattern ECG or
Brugada-type ECG is favorable. Miyasaka et al. reported that one
of 98 subjects with Brugada-pattern ECG with a J-point elevation
Z1 mm and 139 of 13,831 controls died during 2.670.3 years of
follow-up [8]. Matsuo et al. reported that seven of 32 subjects
with Brugada-pattern ECG developed unexpected death in con-
trast to 20 of 4736 subjects with normal ECG during 40 years of
follow-up [11]. Cox survival analysis revealed that mortality was
signiﬁcantly higher in subjects with Brugada-pattern ECG than in
control subjects. Sakabe et al. reported that one of 69 subjects
with Brugada-type ECG with a J-wave amplitude Z2 mm had an
episode of ventricular ﬁbrillation during 4 years of follow-up [13].
Tsuji et al. reported that one of 98 subjects with Brugada-type
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during 7.871.6 years of follow-up, although no one with type
1 ECG died [9]. With regard to juveniles, Oe et al. [14] reported
that none of the four subjects with Brugada-type ECG had an
episode of sudden death or syncope during 6.871.0 years of
follow-up.
The outcome of healthy subjects with Brugada-type ECG is
much better in Western countries. No cardiovascular death
or life-threatening ventricular arrhythmia was observed in 25
individuals during 29.7710.7 months of follow-up in a Greek
population [19], in 15 subjects during 1972 years of follow-up in
a Finnish population [17], and in seven subjects for more than 30
years of follow-up in a Danish population [16]. However, one of
31 subjects died suddenly during 10.175.5 years of follow-up in
an English and an Italian population [20]. Sixty-one subjects
showing Brugada-pattern ECG in a French population did not
die from cardiovascular disease during 49730 months of follow-
up [23]. To summarize, the annual death rate of healthy adults
with Brugada-pattern or Brugada-type ECG is estimated to be less
than 0.5%.7. Conclusions
The prevalence of type 1 ECG in the healthy Asian population
is considered to be around 0.15% in adults and 0.005% in children.
However, it is considered to be less than 0.02% in the Western
population. The prognosis of these subjects is expected to be
good, and the annual death rate is expected to be less than 0.5%.Conﬂict of interest
The author has no conﬂicts of interest to disclose.
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